Año: 2022
Journal Impact Factor (JIF): 11.40
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| HEMATOLOGY | SCIE | 7/79 | Q1 | T1 | D1 |
| ONCOLOGY | SCIE | 23/241 | Q1 | T1 | D1 |
Año: 2022
Journal Citation Indicator (JCI): 1,990
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| HEMATOLOGY | 7/97 | Q1 | T1 | D1 | 93,30 |
| ONCOLOGY | 27/318 | Q1 | T1 | D1 | 91,67 |
Año:
2022
CiteScore:
17,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 18/214 | Q1 | T1 | D1 |
| Hematology | 7/129 | Q1 | T1 | D1 |
| Oncology | 23/366 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
3,376
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Anesthesiology and Pain Medicine | 1/141 | Q1 | T1 | D1 |
| Cancer Research | 18/231 | Q1 | T1 | D1 |
| Hematology | 7/139 | Q1 | T1 | D1 |
| Oncology | 25/397 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| AECC predoctoral fellowship | - |
| AIRC under the Accelerator Award Program | - |
| Cancer Research UK | C355/A26819; C61367/A26670 |
| CIBERONC | CB16/12/00489 |
| ERA-NET Program EraPERMED (MEET-AML) | - |
| ERDF (A way to make Europe) | - |
| ERDF through the Operative Program 2014-2020 of Navarra | PI17/00701; PI20/01308 |
| FC-AECC | AIO16163636SAEZ |
| Fundacion La Caixa | GR-NET NORMAL-HIT HR20-00871 |
| Gobierno de Navarra | 0011-3638-2020-000011; 0011-3597-2020-000005; AGATA 0011-1411-2020-000010/0011-1411-2020-000011 |
| Instituto de Salud Carlos III (ISCIII) | PI17/01346; PI20/00152 |
| LEL-V. Gobierno de Navarra predoctoral fellowship | - |
| Marie Curie grant | H2020-MSCA-IF-837491 |
| MRC | MR/V005421/1; MR/V005421/1; MC_PC_17230 |
| NHS Blood and Transplant | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Viñado, AC | CIBERONC; University of Navarra (Spain) |
| 2 | Calvo, IA | CIBERONC; University of Navarra (Spain) |
| 3 | Cenzano, I | University of Navarra (Spain) |
| 4 | Olaverri, D | University of Navarra (Spain) |
| 5 | Cocera, M | University of Navarra (Spain) |
| 6 | San Martin-Uriz, P | University of Navarra (Spain) |
| 7 | Romero, JP | University of Navarra (Spain) |
| 8 | Vilas-Zornoza, A | University of Navarra (Spain) |
| 9 | Vera, L | University of Navarra (Spain) |
| 10 | Gomez-Cebrian, N | Inst Invest Sanitaria La Fe (Spain) |
| 11 | Puchades-Carrasco, L | Inst Invest Sanitaria La Fe (Spain) |
| 12 | Lisi-Vega, LE | University of Cambridge Department of Haematology; NHS Blood & Transplant (England) |
| 13 | Apaolaza, I | University of Navarra; DATAI Inst Ciencia Datos Inteligencia Artificial (Spain) |
| 14 | Valera, P | University of Navarra (Spain) |
| 15 | Guruceaga, E | University of Navarra (Spain) |
| 16 | Granero-Molto, F | University of Navarra (Spain) |
| 17 | Ripalda-Cemborain, P | University of Navarra (Spain) |
| 18 | Luck, TJ | Free University of Berlin; German Cancer Research Center (DKFZ); Humboldt University of Berlin; Berlin Institute of Health (Germany) |
| 19 | Bullinger, L | Free University of Berlin; German Cancer Research Center (DKFZ) (Germany) |
| 20 | Planes, FJ | University of Navarra; DATAI Inst Ciencia Datos Inteligencia Artificial (Spain) |
| 21 | Rifon, JJ | University of Navarra (Spain) |
| 22 | Méndez-Ferrer, S | University of Cambridge Department of Haematology; NHS Blood & Transplant (England) |
| 23 | Yusuf, RZ | Dana-Farber Cancer Institute (USA) |
| 24 | Pardo-Saganta, A | Justus Liebig University Giessen; German Ctr Lung Res DZL; Univ Giessen & Marburg (Germany) |
| 25 | Prosper, F | CIBERONC; University of Navarra (Spain) |
| 26 | CIBERONC; University of Navarra (Spain) |
